<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04161937</url>
  </required_header>
  <id_info>
    <org_study_id>35/2017</org_study_id>
    <secondary_id>BLSCHP-1603</secondary_id>
    <secondary_id>5DP1ES02545903</secondary_id>
    <nct_id>NCT04161937</nct_id>
  </id_info>
  <brief_title>Work-Site Intervention Study to Prevent Diabetes in Nepal</brief_title>
  <acronym>WSS</acronym>
  <official_title>Work-site Intervention Study to Prevent Diabetes in Nepal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B.P. Koirala Institute of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B.P. Koirala Institute of Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The burden of non-communicable disease is on the rise in low- and middle- income&#xD;
      countries.Cardiovascular disease is the leading cause of morbidity, mortality, and disability&#xD;
      in South Asian regions. Diabetes mellitus is among the top five risk factors for&#xD;
      cardiovascular deaths in the world.&#xD;
&#xD;
      Despite the evidence supporting the use of lifestyle interventions to prevent diabetes and&#xD;
      improve glucose tolerance, their translation in real world has been challenging.&#xD;
      Work-site-based health programs have shown positive impacts on employee health, and have&#xD;
      shown significant improvements in blood glucose levels and HbA1C.&#xD;
&#xD;
      The research will be conducted in 1) Hulas wire Industry and 2) Pragati Textile Industry&#xD;
      Private limited.&#xD;
&#xD;
      Investigator will conduct before-and-after intervention among pre-diabetic employees.In&#xD;
      addition screening will be done to identify the eligible participants.Those who are&#xD;
      pregnant,under diabetic and hypertensive medication will be excluded from the study. All of&#xD;
      the interested adult employees (â‰¥18 years) will be invited for the first screening. All&#xD;
      individuals with HbA1C from 5.7% to 6.4 % will be invited to participate in the study. At&#xD;
      baseline, investigators will administer a standardized questionnaire to record the&#xD;
      characteristics of the participants.Blood samples will be collected and analyzed for HbA1c,&#xD;
      fasting glucose, and lipid profile.&#xD;
&#xD;
      Investigators will have a wait period before implementing any intervention.After completion&#xD;
      of control period,half of the participants will be randomized to receive behavioral&#xD;
      interventions. Behavior intervention will comprise of combination of intensive education&#xD;
      session, group counseling, goal setting and monitoring.Trained nurses will deliver the&#xD;
      sessions once every week for two months and then once every month.All the participants will&#xD;
      receive canteen intervention after behavioral intervention which will comprise of promotion&#xD;
      of healthy foods in the canteen of the study site i.e Improve physical facility ,increase&#xD;
      access to healthy food, Information, Education and communication, changes in food price and&#xD;
      training of canteen staffs Investigators will conduct follow up at 6 months, 12 months, and&#xD;
      18 months and if funds are available at 24 months. During each follow up, the proportion of&#xD;
      unhealthy diet consumption data will be abstracted. In addition, blood samples will be&#xD;
      collected and analyzed for HbA1c, fasting glucose, and lipid profile .This period will serve&#xD;
      as control group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes is the fifth leading cause of death in the most high-income countries and there is&#xD;
      substantial evidence that it is epidemic in many low- and middle-income countries.&#xD;
      Complications from diabetes, such as coronary artery and peripheral vascular disease, stroke,&#xD;
      diabetic neuropathy, amputations, renal failure and blindness results in disability, reduced&#xD;
      life expectancy and enormous health costs.The global age standardized prevalence of diabetes&#xD;
      has nearly doubled since 1980, rising from 4.7% to 8.5% in the adult population.In Nepal,&#xD;
      there is a lack of reliable and representative data on the prevalence of type 2&#xD;
      diabetes.Various small studies from different parts of the country have shown prevalence&#xD;
      rates ranging from 6.3% to 8.5%.The burden of diabetes in terms of disability adjusted life&#xD;
      years has increased almost 100% from 1990 to 2010. A pilot study in an industrial setting&#xD;
      showed a prevalence of 4% diabetes and 31% pre-diabetes among adult employees.The prevention&#xD;
      of type 2 diabetes through lifestyle intervention has been established by several clinical&#xD;
      trials.These studies had a strong focus on increased physical activity and dietary&#xD;
      modification as well as weight reduction among overweight participants. The US Diabetes&#xD;
      Prevention Program clinical trial demonstrated that structured lifestyle interventions-such&#xD;
      as training people with pre-diabetes to achieve modest weight loss through diet and physical&#xD;
      activity-reduced three-year diabetes incidence by 58 percent. Studies have shown that simple&#xD;
      modifications to the physical environment can be important in increasing physical activity&#xD;
      and altering dietary habits. However, the translation of the knowledge to the real world&#xD;
      setting is a challenge. Strategies to translate the preventive measures by innovative and&#xD;
      culturally specific environmental and individual level intervention are lacking.&#xD;
&#xD;
      Work-site could be an effective platform to translate this knowledge into action as employed&#xD;
      adults spend most of their workday waking hours at workplaces.Workplaces have additional&#xD;
      advantages because of convenience to reach people; social support; existing formal and&#xD;
      informal communication networks; and possible corporate behavior network.Studies have shown&#xD;
      positive impact of diabetes prevention at work-site and other&#xD;
      settings.Additionally,environmental changes to the work-sites can achieve modest improvement&#xD;
      in employees' health risks, including weight and body mass index ( BMI) measures, in one year&#xD;
      and reduced glycated hemoglobin(HbA1c) among pre-diabetic adult employee. In 2013,&#xD;
      investigators conducted a survey of cardiovascular disease risk factors among employees of a&#xD;
      wire industry in the eastern Nepal. The study showed that about a third of the employees were&#xD;
      pre-diabetic and 4% had diabetes. Investigators established an ongoing work-site screening&#xD;
      and preventive cardiovascular disease care program in the wire industry in January 2016.&#xD;
      Furthermore, investigators conducted a qualitative study to understand willingness,&#xD;
      facilitators and barriers to promote healthy diet in the industry cafeteria (unpublished).&#xD;
      Building on these ground works, investigators propose implementing and evaluating the&#xD;
      effectiveness of a work-site based lifestyle modification - an environmental modification in&#xD;
      cafeterias and a lifestyle change education package.Investigators propose a pre-post trial&#xD;
      with a control period to assess the effectiveness of the individual level lifestyle&#xD;
      intervention on diabetes risk reduction among pre-diabetic (HbA1c of 5.7 to 6.4%) employees&#xD;
      of two industries in Nepal.Investigators will provide lifestyle education to half of the&#xD;
      randomly selected participants after 6 to 14 months of control period. Additionally,&#xD;
      cafeteria intervention will be provided to all the pre-diabetic participants. The study aims&#xD;
      to:&#xD;
&#xD;
      Aim 1: To measure the effectiveness of an environmental-level cafeteria intervention on&#xD;
      diabetes risk.&#xD;
&#xD;
      Aim 2: To measure the effectiveness of an individual-level lifestyle education on the risk of&#xD;
      diabetes prevention.&#xD;
&#xD;
      If the program is shown to be effective at these work-sites, the results of this study will&#xD;
      be used to recommend and disseminate a sustainable environment and lifestyle interventions at&#xD;
      work-sites to improve the health of workers, other Nepali work-sites, and to Nepal's national&#xD;
      program for prevention and control of non- communicable disease. Furthermore, lessons from&#xD;
      this study can be used to make recommendations or plan studies of similar work-site programs&#xD;
      in the U.S. and other settings outside of Nepal.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>We have intervention and control arm and at the same time parellel</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1C</measure>
    <time_frame>24months</time_frame>
    <description>The primary outcome is absolute change in HbA1c</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">163</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Behavioural Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Half of the randomly selected participants will get behavioural intervention based on Diabetes Prevention Program module.The behavioural intervention classed will be administered by trained nurse weekly for 16 weeks.After completion of behavioural intervention both the experimental and control arm will get cafeteria intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Half of the participants will act as a control and will not receive any form of behavioural intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioural Intervention</intervention_name>
    <description>Behavior intervention will comprise of combination of intensive education session, group counseling, goal setting and monitoring based on the Diabetes Prevention Program (DPP).The curriculum includes 24 sessions: 16 core sessions weekly during the first four months of the program followed by a monthly maintenance sessions.</description>
    <arm_group_label>Behavioural Intervention</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1) Pre-diabetic participants (HbA1c 5.7-6.4%) and FBS (&gt;=100 to 125mg/dl)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diabetic - HbA1c (&gt;=6.5%) and FBS &gt; 126mg/dl&#xD;
&#xD;
          2. HbA1c &lt;5.7% and FBS &lt;100mg/dl&#xD;
&#xD;
          3. Taking hypertension,diabetes medication&#xD;
&#xD;
          4. Pregnancy&#xD;
&#xD;
          5. Temporary workers&#xD;
&#xD;
          6. Age &lt;18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hulas Wire industry Private Limited and Pragati Textile Industry Private Limited</name>
      <address>
        <city>Biratnagar</city>
        <state>Provinve 1</state>
        <zip>56700</zip>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 10, 2019</study_first_submitted>
  <study_first_submitted_qc>November 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2019</study_first_posted>
  <last_update_submitted>November 14, 2019</last_update_submitted>
  <last_update_submitted_qc>November 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>B.P. Koirala Institute of Health Sciences</investigator_affiliation>
    <investigator_full_name>Dr. Prajjwal Pyakurel</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Work-site</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Nepal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We will decide later on</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

